On 2025-05-15, Gossamer Bio, Inc. (GOSS) announced earnings per share of $-0.16 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.18.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.18 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.18 | $-0.16 |
| 2025-03-13 | 2024-12-31 | $-0.17 | $-0.15 |
| 2024-11-07 | 2024-09-30 | $-0.18 | $-0.14 |
| 2024-08-12 | 2024-06-30 | $0.23 | $0.22 |
| 2024-05-07 | 2024-03-31 | $-0.19 | $-0.19 |
| 2024-03-05 | 2023-12-31 | $-0.20 | $-0.21 |
| 2023-11-09 | 2023-09-30 | $-0.20 | $-0.21 |
| 2023-08-08 | 2023-06-30 | $-0.49 | $-0.45 |
| 2023-05-09 | 2023-03-31 | $-0.55 | $-0.52 |
| 2023-03-17 | 2022-12-31 | $-0.62 | $-0.59 |
| 2022-11-03 | 2022-09-30 | $-0.66 | $-0.65 |
| 2022-08-09 | 2022-06-30 | $-0.67 | $-0.74 |
| 2022-05-10 | 2022-03-31 | $-0.77 | $-0.76 |
| 2022-03-03 | 2021-12-31 | $-0.74 | $-0.74 |
| 2021-11-08 | 2021-09-30 | $-0.78 | $-0.80 |
| 2021-08-09 | 2021-06-30 | $-0.77 | $-0.80 |
| 2021-05-06 | 2021-03-31 | $-0.80 | $-0.78 |
| 2021-02-25 | 2020-12-31 | $-0.80 | $-0.88 |
| 2020-11-10 | 2020-09-30 | $-0.86 | $-0.80 |
| 2020-08-11 | 2020-06-30 | $-0.84 | $-1.00 |
| 2020-05-12 | 2020-03-31 | $-0.80 | $-0.87 |
| 2020-03-24 | 2019-12-31 | $-0.80 | $-0.89 |
| 2019-11-12 | 2019-09-30 | $-0.71 | $-0.80 |
| 2019-08-08 | 2019-06-30 | $-0.56 | $-0.74 |
| 2019-05-14 | 2019-03-31 | $-0.63 | $-0.90 |